Greenwood-Lee, James
Jewett, Lauren
Woodhouse, Linda
Marshall, Deborah A. http://orcid.org/0000-0002-8467-8008
Funding for this research was provided by:
Alberta Innovates - Health Solutions (201300472)
Arthritis Society (Models of Care Catalyst Grant MOC-13-007)
Institute of Health Services and Policy Research (Planning Grant 20132PLH)
Article History
Received: 23 April 2018
Accepted: 21 November 2018
First Online: 20 December 2018
Ethics approval and consent to participate
: Not Applicable.
: Not Applicable.
: JGL and LJ declare the following interests: NoneDM declares the following interests: Ad hoc consulting for Optum, a health economics and outcomes research global company. Honoraria and travel expenses as a member of Pfizer HTA Advisory Board, honoraria and travel expenses for a seminar for Abbvie, honoraria and travel expenses for a presentation for Novartis, honoraria and travel expenses for a presentation for Janssen.Unpaid officerships - President and member of Board of Directors, International Society for Pharmacoeconomics and Outcomes Research, and member of Board of Directors, Health Technology Assessment International, Editorial Board The Patient, Editorial Board, International Society for Technology Assessment in Health Care.LW declares the following interests: Funding from Eli Lilly for myostatin trial design and serving on an advisory board for myostatin development.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.